JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2002) 172, 489-495       DOI: 10.1677/joe.0.1720489
© 2002 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Span, P.
Right arrow Articles by Sweep, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Span, P.
Right arrow Articles by Sweep, C.
Journal of Endocrinology, Vol 172, Issue 3, 489-495
Copyright © 2002 by Society for Endocrinology


Articles

Analysis of expression of chorionic gonadotrophin transcripts in prostate cancer by quantitative Taqman and a modified molecular beacon RT-PCR

PN Span, CM Thomas, JJ Heuvel, RR Bosch, JA Schalken, L vd Locht, EJ Mensink, and CG Sweep


Expression of human chorionic gonadotrophin (hCG) is associated with trophoblastic, testicular and other malignancies such as bladder, pancreatic, cervical, breast and prostate cancer. In the prostate, however, hCG expression, associated with neuroendocrine cells, is also found in normal tissue. Of the six highly homologous genes that all encode the beta-subunit of hCG, the beta 7 gene is reportedly the only gene expressed in several non-transformed tissues. The beta 3, 5 and 8 genes would be variably expressed in malignant tissue and placenta, but not in normal tissue. To assess to what extent this expression difference can also be found in the prostate, we compared the levels of the different hCG beta transcripts in concurrent normal and cancerous prostate tissues obtained from 17 patients. To this end, we developed a Taqman real-time fluorescent RT-PCR assay for hCG beta, and a quantitative assay specific for the beta 3, 5 and 8 genes, modified from the molecular beacon principle. This latter assay proved highly specific and capable of reliably distinguishing between these hCG beta transcripts that differ in only one nucleotide. Surprisingly, median expression levels of hCG beta were lower in prostate cancer when compared with normal tissue from the same patient. In contrast, hCG beta 3, 5 and 8 transcripts were found in normal tissue and did not differ in prostate cancer, arguing against a specific role of these transcripts in the development of prostate cancer.


This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
K. Hotakainen, S. Lintula, B. Ljungberg, P. Finne, A. Paju, U.-H. Stenman, and J. Stenman
Expression Of Human Chorionic Gonadotropin {beta}-Subunit Type I Genes Predicts Adverse Outcome In Renal Cell Carcinoma
J. Mol. Diagn., November 1, 2006; 8(5): 598 - 603.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Rull and M. Laan
Expression of {beta}-subunit of HCG genes during normal and failed pregnancy
Hum. Reprod., December 1, 2005; 20(12): 3360 - 3368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. A. Mathias, J. Hitti, and J. D. Unadkat
P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R963 - R969.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. N. Span, P. Manders, J. J.T.M. Heuvel, C. M.G. Thomas, R. R. Bosch, L. V.A.M. Beex, and C.G.J. Sweep
Molecular Beacon Reverse Transcription-PCR of Human Chorionic Gonadotropin-{beta}-3, -5, and -8 mRNAs Has Prognostic Value in Breast Cancer
Clin. Chem., July 1, 2003; 49(7): 1074 - 1080.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.